APRI score non-invasive marker of metabolic syndrome in breast carcinoma patients
ConclusionAPRI score can be used as a surrogate marker of metabolic syndrome in patients with breast carcinoma. It is also useful in planning preventive strategies in patients with breast carcinoma especially in post-menopausal age group.
Source: Clinical Epidemiology and Global Health - Category: Epidemiology Source Type: research
More News: Alcoholism | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Eating Disorders & Weight Management | Epidemiology | Hepatocellular Carcinoma | Liver | Liver Cancer | Men | Menopause | Metabolic Syndrome | Obesity | Study | Sugar | Urology & Nephrology | Women